Lazard Asset Management’s Addus HomeCare ADUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,869
Closed -$2.89M 1859
2025
Q4
$2.89M Buy
26,869
+11,682
+77% +$1.34M ﹤0.01% 728
2025
Q3
$1.79M Buy
15,187
+8,513
+128% +$955K ﹤0.01% 899
2025
Q2
$767K Sell
6,674
-527
-7% -$56.9K ﹤0.01% 1377
2025
Q1
$711K Sell
7,201
-19,328
-73% -$2.15M ﹤0.01% 1320
2024
Q4
$3.33M Sell
26,529
-3,752
-12% -$474K ﹤0.01% 734
2024
Q3
$4.03M Buy
30,281
+2,693
+10% +$340K 0.01% 690
2024
Q2
$3.2M Buy
27,588
+22,460
+438% +$2.4M ﹤0.01% 781
2024
Q1
$529K Buy
5,128
+547
+12% +$51.1K ﹤0.01% 1044
2023
Q4
$424K Buy
4,581
+2,334
+104% +$203K ﹤0.01% 1160
2023
Q3
$190K Sell
2,247
-512
-19% -$45.6K ﹤0.01% 1402
2023
Q2
$254K Buy
2,759
+2,729
+9,097% +$260K ﹤0.01% 1280
2023
Q1
$3K Sell
30
-278
-90% -$29K ﹤0.01% 2175
2022
Q4
$30K Buy
+308
New +$32.2K ﹤0.01% 2014
2021
Q1
Sell
-472
Closed -$55K 1835
2020
Q4
$55K Buy
472
+392
+490% +$40.5K ﹤0.01% 1349
2020
Q3
$7K Buy
+80
New +$7.49K ﹤0.01% 1510
2020
Q2
Sell
-5,063
Closed -$342K 1605
2020
Q1
$342K Buy
+5,063
New +$438K ﹤0.01% 842

Other funds holding ADUS

Lazard Asset Management's ADUS Position: Q1 2026 in Review

Lazard Asset Management sold out of Addus HomeCare (ADUS) in Q1 2026, closing a stake of 26,869 shares — an estimated $2.89M sold.

Lazard Asset Management first reported a position in ADUS in Q1 2020 and held it in 16 quarters. The position peaked at $4.03M in Q3 2024. 298 funds tracked by Wall St. Rank hold ADUS as of Q1 2026.

  • Lazard Asset Management reported no remaining Addus HomeCare position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 26,869 Addus HomeCare shares in Q1 2026, an estimated $2.89M.
  • Lazard Asset Management first reported a position in Addus HomeCare in Q1 2020 and held it in 16 quarters.
  • Lazard Asset Management's Addus HomeCare position peaked at $4.03M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Addus HomeCare as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.